- Disease Risk Management
A hot application scenario of medical artificial intelligence is disease risk management. When applies to a specific disease treatment area, AI can improve the diagnosis accuracy and reduce misdiagnosis. However, if AI can be used for chronic diseases treatment, more patients will benefit from the new technologies. For example, the retina recognition algorithm can identify more than 30 kinds of chronic diseases, including complications of systemic chronic diseases such as diabetes, hypertension, arteriosclerosis and optic nerve diseases, and common ophthalmic diseases such as high myopia and age-related macular degeneration.
AI chip: The AI chip is small in size, low in power consumption, high in real-time calculation, and low in price. It provides high-performance hardware acceleration for artificial intelligence and deep learning computing for medical image processing, giving high-performance, high-reliability, real-time deep learning computing capabilities to intelligent terminals.
Hospital logistics: Hospital logistics is characterized by the combination of logistics, medical equipment, and special item management. Traditional hospital logistics consumes a lot of manpower and financial resources, and there are still many disadvantages: high transportation costs and difficult to management, high error rate, security and insecurity, occupy management workload, infection, etc. The use of medical intelligence logistics robots solves these problems. Department personnel can manage the transportation tasks through the terminal.
Primary care: At present, there is a large demand for technicians who are skilled in operating equipments and setting scanning parameters and doctors who can read the films and accurately determine the condition. The use of artificial intelligence solves these problems.
Artificial intelligence has a huge impact on the medical sector, driving the development of medical testing, imaging diagnosis, hospital logistics, primary medical care, etc. In the future, new artificial intelligence products will be introduced to constantly improve the work efficiency of doctors and hospitals, and also provide a strong guarantee for human to fight against diseases.
China State Council published an article on AI medical device on July 9th, aiming to propel China to the leadership of AI devices.
For more information about AI medical device in China, please email info@ChinaMedDevice.com.
About China Med Device, LLC
China Med Device, LLC (https://ChinaMedDevice.com/) provides turn-key solutions for western medical device/IVD companies to enter China with regulation and commercialization services. Our CFDA regulatory services cover strategy, RA, clinical evaluation, CRO, QA and post market compliance. We are experienced in handling innovation approvals and priority reviews. Our commercial services cover market assessment research, reimbursement, partnership, distribution qualification and management. We have offices in Beijing, Suzhou and Boston. Our management team has 100+ years of combined experience in medical device and IVD and has been involved with 1,000+ CFDA certificates and 250+ companies’ success.